Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK Inhibitors (2025)
Attributed to:
LIMK1 inhibitors - A novel, disease-modifying approach for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.5c00974
Publication URI: http://dx.doi.org/10.1021/acs.jmedchem.5c00974
Type: Journal Article/Review
Parent Publication: Journal of Medicinal Chemistry
Issue: 16